Aurinia Pharmaceuticals reported cash from operations of $52.57M and free cash flow of $52.57M for the quarter ended Jun 2026, up 18.8% year over year. This cash flow statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||
| Net Income | -50.26M | -33.32M | -37.63M | -35.52M | -8.99M | -26.05M | -26.21M | -11.49M | -13.45M | -26.87M | -10.75M | 0.68M | 14.31M | 1.48M | 23.34M | 21.51M | 31.55M | 210.84M | 34.33M | 37.39M | |||||||
| Share-based CompensationStock Comp. | 7.09M | 8.58M | 7.02M | 10.05M | 8.32M | 6.90M | 9.47M | 12.27M | 11.81M | 11.77M | 5.74M | 8.59M | 8.33M | 8.95M | 8.93M | 0.10M | 0.36M | 5.28M | 14.58M | 11.87M | |||||||
| Deferred Taxes | 9.28M | 11.11M | |||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.24M | 1.18M | |||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -40.25M | -25.92M | -46.75M | -27.87M | -15.36M | 10.45M | -31.67M | -2.83M | -13.28M | 14.31M | -18.60M | 15.84M | 17.03M | 30.11M | 1.30M | 44.24M | 44.45M | 45.67M | 32.56M | 52.57M | |||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.15M | -0.50M | 0.36M | 1.56M | 2.61M | 2.99M | 3.24M | 3.31M | 3.21M | 3.12M | 3.42M | 2.98M | 2.66M | 2.56M | 2.62M | 2.33M | 2.32M | 1.88M | |||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 4.85M | 4.84M | 4.89M | 4.86M | 4.86M | 4.86M | 4.87M | 4.86M | 4.82M | 4.83M | |||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 5.40M | 5.60M | 4.99M | -2.23M | 23.60M | -28.28M | 5.56M | 0.46M | 18.45M | -13.86M | 4.82M | -3.39M | 10.96M | 0.06M | 3.81M | -0.26M | -9.36M | 10.73M | 7.72M | -8.04M | |||||||
| Change in InventoryChange Inventory | 1.92M | 0.28M | 6.94M | 1.01M | 0.51M | 0.61M | 6.99M | 1.41M | 0.58M | 6.88M | 0.06M | -0.91M | -0.14M | 0.51M | 6.97M | 0.31M | -1.71M | 0.90M | 0.72M | -1.26M | |||||||
| Change in Account PayablesChange Payables | 1.34M | 2.74M | 0.46M | -3.69M | -0.97M | -0.90M | -1.10M | 1.10M | -0.65M | -2.80M | |||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.12M | 2.93M | -6.70M | 0.46M | 7.12M | 0.62M | -4.12M | 5.36M | 10.57M | 0.34M | -7.94M | 4.13M | -0.33M | 17.47M | -23.41M | 6.27M | -0.64M | 13.12M | -5.59M | 0.56M | |||||||
| Other Working Capital ChangesOther WC Changes | -0.00M | -0.64M | 1.17M | 5.27M | 4.34M | 0.81M | -1.00M | -0.48M | 1.08M | 0.62M | |||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||
| Capital ExpendituresCapex | 3.50M | 0.08M | 0.44M | 0.31M | -0.47M | 0.35M | 0.18M | -0.10M | 0.30M | -0.02M | 0.16M | 0.09M | 0.06M | 0.02M | -0.75M | 0.04M | |||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 99.10M | 90.67M | 110.57M | 115.11M | 120.43M | 118.21M | 167.77M | 120.53M | 103.00M | 138.09M | 170.50M | 158.37M | 132.57M | 123.97M | 123.03M | 132.25M | 93.50M | 145.35M | 109.00M | 100.00M | |||||||
| Cash from Investing ActivitiesCash from Investing | -32.81M | -5.49M | -53.02M | 45.62M | -50.22M | -3.02M | 24.86M | -5.61M | -19.70M | -6.26M | 49.23M | -38.62M | -10.57M | 39.22M | 31.03M | -13.27M | -13.77M | -36.76M | -18.08M | 81.45M | |||||||
| Financing Activities | |||||||||||||||||||||||||||
| Other financing activitiesOther financing | 9.07M | 9.02M | 0.41M | 1.34M | -0.18M | 1.64M | 1.14M | 1.15M | 1.40M | 5.52M | 0.61M | 0.40M | 1.65M | 9.29M | 1.30M | 1.99M | 1.61M | 0.71M | 58.44M | ||||||||
| Cash from Financing ActivitiesCash from Financing | 9.08M | 205.72M | 0.41M | 1.34M | 0.69M | 1.64M | 1.14M | -2.33M | -5.58M | -15.05M | -8.27M | -2.72M | -23.05M | -49.34M | -44.39M | -10.49M | -1.89M | -53.69M | 4.81M | ||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 196.74M | 0.38M | 0.35M | ||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||
| Change in Cash | -63.97M | 174.31M | -99.36M | 19.09M | -65.58M | 8.12M | -5.17M | -7.29M | -35.31M | 2.48M | 15.58M | -31.05M | 3.73M | 46.29M | -17.00M | -13.43M | 20.19M | 7.02M | -39.20M | 138.82M | |||||||
| Free Cash FlowFCF | -43.75M | -25.92M | -46.83M | -28.31M | -15.68M | 10.92M | -32.02M | -3.00M | -13.17M | 14.01M | -18.58M | 15.69M | 16.94M | 30.06M | 1.28M | 44.99M | 44.45M | 45.67M | 32.52M | 52.57M | |||||||
| Net Cash FlowNCF | -63.97M | 174.31M | -99.36M | 19.09M | -65.58M | 8.12M | -5.17M | -7.29M | -35.31M | 2.48M | 15.58M | -31.05M | 3.73M | 46.29M | -17.00M | -13.43M | 20.19M | 7.02M | -39.20M | 138.82M |